CSX Corporation
CSXLast close · Oct 16, 202648.68−0.01 (−0.02%)
Market cap$90.2B
8 firms' latest targets, last 90 days: median $53.50 ($51.00–$60.00), 10% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-15 | Raymond James | $53.00 | ▼ 5% | +9% |
| 2026-09-24 | RBC Capital | $53.00 | ▼ 2% | +9% |
| 2026-07-31 | Argus Research | $56.00 | — | +15% |
| 2026-07-24 | Deutsche Bank | $59.00 | — | +21% |
| 2026-07-23 | Stifel | $54.00 | — | +11% |
| 2026-07-23 | BMO Capital | $52.00 | ▲ 16% | +7% |
| 2026-07-23 | Evercore ISI | $51.00 | ▲ 9% | +5% |
| 2026-07-23 | Barclays | $60.00 | ▲ 9% | +23% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $14.7B | -1% | $1.85 | -5% | est. $14.6B+0% | est. $1.83 | 15 |
| 2024reported | $14.5B | -1% | $1.79 | -3% | est. $14.6B+0% | est. $1.83 | 13 |
| 2025reported | $14.1B | -3% | $1.54 | -14% | est. $14.1B+0% | est. $1.64 | 13 |
| 2026 | $15.3B | +8% | $2.01 | +22% | $15.0B–$15.6B | $1.94–$2.07 | 15 |
| 2027 | $16.1B | +5% | $2.29 | +14% | $15.6B–$16.3B | $2.20–$2.41 | 15 |
| 2028 | $16.6B | +3% | $2.53 | +10% | $16.2B–$17.2B | $2.37–$2.62 | 13 |
| 2029 | $17.5B | +5% | $2.76 | +9% | $17.1B–$18.0B | $2.68–$2.86 | 11 |
| 2030 | $18.4B | +5% | $2.94 | +6% | $17.9B–$18.9B | $2.84–$3.03 | 6 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.